You are here: Home » Markets ¬Ľ News
DHFL plunges 19% in two days after CRISIL's credit rating downgrade
icon-arrow-left
Business Standard

Divis Laboratories on strong growth trend, experts expect margins to expand

Strong demand for active ingredients is further accentuated by shortages even as prospects in custom synthesis business remain firm

Topics
Divis Laboratories  |  Investors

Ujjval Jauhari  |  New Delhi 



Lupin to develop Brazil as Latin American manufacturing, export hub
Representative Image

is trading near its all-time high and has returned about 38 per cent to in the last six months. The firm remains an exporter of generic active pharmaceutical ingredients (about 56 per cent of FY18 revenues) and custom synthesis (CRAMS, about 44 per cent of FY18 revenues). It has continued to benefit from strong demand for both.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Mon, April 22 2019. 16:19 IST

RECOMMENDED FOR YOU

.